Loading clinical trials...

Telehealth-Enhanced Asthma Care for Home After the Emergency Room | Clinical Trials | Clareo Health

RECRUITINGNA

Telehealth-Enhanced Asthma Care for Home After the Emergency Room

Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)

NCT05844891•University of Rochester

Summary

The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications; 2) virtual primary care follow-up within 1 week of discharge using in-home telemedicine (Zoom) when possible, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans; 3) two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices. The investigators will enroll 430 children (ages 3-12 yrs) from the two dedicated pediatric EDs in our region, and follow all participants for a 12-month period. The investigators will call caregivers to complete blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge. The investigators will assess the effectiveness of TEACH-ER in reducing the need for additional asthma-related ED visits or hospitalizations in the 1-months after enrollment. Additional outcomes of interest include asthma symptoms, medication adherence, absenteeism from work and school, quality of life, and the delivery of care consistent with national asthma care guidelines.

Eligibility

Age

3 - 12 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Physician diagnosis of asthma, based on review of medical records and/or caregiver report.
•Current emergency visit for an acute asthma exacerbation, requiring treatment with rescue medication.
•Persistent asthma or poor asthma control for which a daily controller medication is recommended by NHLBI guidelines, defined as any 1 of the following:
•1. \>2 days/wk with asthma symptoms in the past month,
•2. \>2 days/wk with rescue medication use in the past month,
•3. \>2 days/month with nighttime symptoms in the past month (vs. 1-2 nights per month if 3-4 years old), or
•4. ≥1 other episode of asthma during the past year that required systemic corticosteroids (vs. during the past 6 months if 3-4 years old).
•Child age between ≥3 and ≤12 years.
•Child and caregiver live in Monroe County, NY.

Exclusion Criteria

•An inability to speak and understand English. Parents (and children) with low literacy / health-literacy skills will be eligible, as survey instruments will be administered verbally and educational materials will be designed for low-literacy populations.
•No access to a working phone for follow-up surveys (either at the subject's home or an easily accessible location). If a subject does not have access to an appropriate device for Zoom visits at home, we will provide a device with required data plan.
•Other significant medical conditions, including cystic fibrosis, congenital heart disease, or other chronic lung disease, that could interfere with the assessment of asthma-related measures.
•Children in foster care or other situations in which consent cannot be obtained from a legal guardian.

Locations (1)

University of Rochester Medical Center

Rochester, New York, United States

Key Dates

Start Date

April 1, 2024

Primary Completion Date

March 31, 2028

Completion Date

June 30, 2028

Last Updated

April 22, 2025

Enrollment

430

ESTIMATED participants

Conditions

Asthma in Children

Interventions

Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)

BEHAVIORAL

Enhanced Care (EC)

BEHAVIORAL

ASMact: Study on Management of Bronchial Asthma

NCT07412769

Asthma AcuteAsthma Childhood+2 more

View study

RECRUITINGNA

Reducing Asthma Attacks in Disadvantaged School Children With Asthma

NCT06003569

Asthma in Children

View study

RECRUITINGPHASE2

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 22, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Telehealth-Enhanced Asthma Care for Home After the Emergency Room

Inclusion Criteria

Exclusion Criteria

ASMact: Study on Management of Bronchial Asthma

Reducing Asthma Attacks in Disadvantaged School Children With Asthma

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)

Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)

Omalizumab Before Onset of Exacerbations